Doctor Image

Dr. Munish Gairola

MBBS. MD, DNB


Director Radiation Oncology

Book an Appointment

Rajiv Gandhi Cancer Institute, Sector - 5, Rohini, Delhi - 110 085

Rajiv Gandhi Cancer Institute, Mahender Kumar Jain Marg, Niti Bagh, New Delhi, Delhi 110049

About

Dr. Munish Gairola , MD DNB Radiation Oncology with over 30 yrs. of experience in the field of oncology.   He completed his MBBS from G.S.V.M. Medical College, Kanpur, MD from Kanpur University and subsequently worked in Post Graduate Institute of Medical Education & Research (PGIMER) Chandigarh and All India Institute of Medical Sciences (AIIMS), New Delhi for several years.

He worked in Christie’s Hospital, Manchester, UK as clinical fellow and IMRT Fellow at Memorial Sloan Kettering Cancer Centre (MSKCC) New York, USA.   He has also received UICC fellowship for National Defence Medical College (NDMC) Saitama, Japan. Dr. Gairola has published many articles in various International and National Journals. Presently Dr Munish Gairola is working as Director Radiation Oncology at Rajiv Gandhi Cancer Institute & Research Centre (RGCI & RC), Delhi.

Specialized Areas

  • Head & Neck Cancer – High conformal techniques viz IMRT, IGRT, Adaptive Radiotherapy, Brachytherapy
  • CNS Cancers- High Precision techniques viz Stereotactic Radiotherapy(SRT), Stereotactic Radiosurgery (SRS)
  • Paediatric Cancers
  • Lung Cancer – Stereotactic Body Radiotherapy (SBRT), Stereotactic Ablative Body Radiotherapy (SABR), Image Guided Radiotherapy (IGRT)

Educational Background

  • IMRT Fellow, Memorial Sloan Kettering Cancer Centre(MSKCC), NY, USA
  • Clinical Research Fellow, Chirstie Hospital, Manchester, UK
  • DNB (Radiation Oncology) , National Board of Examination, New Delhi, India
  • MD (Radiation Oncology) J K Cancer Institute ,GSVM Medical College, Kanpur, India
  • MBBS, GSVM Medical College, Kanpur, UP, India

Experience

  • 1990- 1993 – JUNIOR RESIDENT (Resident Teaching Fellow) To Radiotherapy, J.K. Cancer Institute and G.S.V.M. Medical College Kanpur
  • 1993- 1994 – SENIOR REGISTRAR in  Department Of Radiotherapy and Oncology Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh
  • 1995 – 1999 – SENIOR RESIDENT In the Department of Radiotherapy, All India Institute of Medical Sciences (AIIMS), New Delhi
  • 1999- 2002 – RESEARCH OFFICER in IAEA Project of Multi-Institutional Trial on Altered Fractionation of Radiation Therapy (5# Vs 6#) In Head and Neck Cancers. (Chief Co-Coordinator- Prof Jens Overgaard- Danish Cancer Institute)
  • 1993- 1993 – CLINICAL RESEARCH FELLOW At Christie’s Hospital Manchester, U.K.
  • 2004- 2004 – CLINICAL OBSERVER for IMRT in Head & Neck and Brain tumours at Memorial Sloan Kettering Cancer Centre (MSKCC), New York, USA

Professional Journey

Awards

  • Received Medical Excellence Award -2014 for valuable Contribution in radiation Oncology
  • Travel Fellowship to Attend ESTRO-EORTC Meeting at Brussels, Belgium on Radiation for Benign Disease by Department Of Science and Technology (DST), India
  • Travel Fellowship to Attend International Congress of Radiation Oncologists (ICRO-2001) Held at Melbourne, Australia by Ministry Of Human Resource & Development (HRD), India
  • Travel Grant to Attend International Congress of Radiation Oncologist (ICRO-2001) held at Melbourne, Australia by International Society of Radiation Oncologist (ISRO)
  • UICC Fellowship (UICC-ICRETT) awarded to Visit National Defence Medical College, Saitama, Japan
  • Grant from UICC & Norwegian Cancer Society Grant to Attend 18th UICC Congress held At Oslo, Norway June /July 2003.
  • Travel Fellowship to attend 18th UICC Congress Held at Oslo, Norway June /July 2003 by Department Of Science And Technology (DST), India

Publication

  • Is it too early to recommend local treatment in oligometastatic NSCLC: a plea for equipoise 10.1093/bjr/tqae068. British Journal of Oncology 2024
  • Cardiac markers in left-sided breast cancer patients receiving adjuvant radiotherapy: a prospective study. 10.1186/s40959-024-00225-1. Cardio-oncology 2024
  • Role of neoadjuvant therapy in resectable pancreatic carcinoma: a review article
  • Survival Outcomes in Different Sino-nasal Malignancies: An Institutional Review. 10.1177/25898892241232746. Journal of Current Oncology 2024
  • Primary Oropharyngeal SMARCA4-Deficient Carcinoma: Expanding the Diagnostic Spectrum in Head and Neck Cancer. 10.1007/s12105-024-01614-9. Head and Neck Pathology 2024
  • Time saved is time earned: Implementation of an agile workflow system in a high-volume radiation oncology centre Workflow optimization in radiation oncology. 10.21203/rs.3.rs-4015333/v1. Preprint
  • Indian clinical practice consensus guidelines for the management of very advanced head-and-neck squamous cell carcinoma: Update 2022. Cancer Research Statistics and Treatment 2024
  • Indian clinical practice consensus guidelines for the management of oral cavity cancer: Update 2022. Cancer Research Statistics and Treatment 2024
  • Introduction to Indian clinical practice consensus guidelines for the management of squamous cell carcinoma the head-and-neck: Update 2022. Cancer Research Statistics and Treatment 2024
  • Indian clinical practice consensus guidelines for the management of hypopharyngeal cancer: Update 2022. Cancer Research Statistics and Treatment 2024
  • Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer: Update 2022. Cancer Research Statistics and Treatment 2024
  • Indian clinical practice consensus guidelines for the management of oropharyngeal cancer: Update 2022. Cancer Research Statistics and Treatment 2024
  • Indian clinical practice consensus guidelines for the management of laryngeal cancer: Update 2022. Cancer Research Statistics and Treatment 2024
  • Effectiveness of Head-and-Neck Molecular Imaging Reporting and Data System Criterion in Head-and-Neck Squamous Cell Carcinoma PostConcurrent Chemoradiotherapy. Indian Journal of Nuclear Medicine 2023
  • A practical and practicable framework for implementing cardiac-sparing radiotherapy techniques in breast cancer. Cancer Research Statistics and Treatment 2023
  • Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohort. The British journal of radiology 2023
  • Risk-Adapted Target Delineation for Breast Cancer: Controversies and Considerations. Practical Radiation Oncology 2022
  • To Study the Impact of Different Optimization Methods on Intensity-Modulated Radiotherapy and Volumetric-Modulated Arc Therapy Plans for Hip Prosthesis Patients. Journal of Medical Physics. 2022
  • Virtual Training on IGRT: A Unique Initiative of a Private Cancer Center from a Developing Country with Regional Academic Collaboration during COVID-19 Pandemic. International Journal of Radiation Oncology*Biology*Physics 2022
  • Immunotherapy in Advanced Non-Small-Cell Lung Cancer (NSCLC) After Progression on Chemotherapy: Real-World Results from a Prospective Institutional Cohort. Immunotherapy 2022
  • Combined Diagnostic Accuracy of Diffusion and Perfusion MR Imaging to Differentiate Radiation-Induced Necrosis from Recurrence in Glioblastoma. Diagnostics 2022
  • Depth of Invasion as an Independent Predictor of Survival in Patients of Stage III Squamous Cell Carcinoma of the Oral Tongue. The Laryngoscope 2021
  • Indian clinical practice consensus guidelines for the management of nasopharyngeal cancer. Indian J Cancer. 2020 Feb;57(Supplement):S9–11.
  • Value of diffusion MR imaging in differentiation of recurrent head and neck malignancies from post treatment changes. Oral Oncol. 2020;96:89–96.
  • Indian clinical practice consensus guidelines for the management of oral cavity cancer. Indian J Cancer. 2020 Feb;57(Supplement):S6–8.
  • Indian clinical practice consensus guidelines for the management of oropharyngeal cancer. Indian J Cancer. 2020 Feb;57(Supplement):S12–5
  • Indian clinical practice consensus guidelines for the management of laryngeal cancer. Indian J Cancer. 2020 Feb;57(Supplement):S19–21.
  • Indian clinical practice consensus guidelines for the management of very advanced disease of squamous cell carcinoma of head and neck. Indian J Cancer. 2020 Feb;57(Supplement):S22–5.
  • Indian clinical practice consensus guidelines for the management of squamous cell carcinoma of head and neck. Indian J Cancer. 2020 Feb;57(Supplement):S1–5.
  • Pseudoprogression on 68Ga- Prostate-Specific Membrane Antigen-11 PET/CT in a Treated Glioblastoma. Clin Nucl Med. 2020 Aug;45(8):621–2.
  • Impact of acuros XB algorithm in deep-inspiration breath-hold (DIBH) respiratory techniques used for the treatment of left breast cancer. Rep Pract Oncol Radiother. 2020 Aug;25(4):507–14.
  • Malignant esophagorespiratory fistulas: a comparative effectiveness survival analysis. BMJ Support Palliat Care. 2020 Aug 21
  • Role of 68Ga-Prostate-Specific Membrane Antigen PET/CT in Disease Assessment in Glioblastoma Within 48 Hours of Surgery. Clin Nucl Med. 2020 Mar;45(3):204–5.
  • A case report evaluating combined effect of intensity-modulated radiotherapy and deep inspiratory breath-hold for mediastinal lymphoma: A dosimetric analysis. Lung India. 2020 Feb;37(1):57–62.
  • Use of definitive locoregional radiotherapy for consolidation in de-novo metastatic head and neck cancer responding to systemic therapy
  • “Radiation Recall Phenomenon” with Novel Cytotoxic Agents: An Emerging Trend in the Last Decade. Indian Journal of Medical and Paediatric Oncology 42(2021;42:28-34) May 2021
  • Role of Functional Imaging in evaluation of Radiation Colitis. Radiation and Oncology 2020
  • Use of definitive locoregional radiotherapy for consolidation in de-novo metastatic head and neck cancer responding to systemic therapy. Accepted in Indian Journal of Cancer
  • Inter-correlation between various high risk pathological risk factors in squamous cell carcinoma tongue. ESTRO 2021
  • Pre-treatment hemoglobin as a surrogate marker for survival in head and neck squamous cell carcinoma. ESTRO 2021
  • Survival outcomes comparison between simultaneous integrated boost IMRT and sequential IMTRT in head and neck cancer. ESTRO 2021
  • Tumour volume as a prognostic factor for recurrent head and neck cancers treated with re-irradiation. ESTRO 2021
  • Comparison between two-dose levels versus three-dose levels in IMRT in head and neck cancers. ESTRO 2021
  • Impact of anterior commissure involvement in early glottic cancer treated with radical IMRT. ESTRO 2021
  • Dosimetric impact of tumour regression in carcinoma cervix treated with radical IMRT. ESTRO 2021
  • Impact of human papilloma virus on treatment outcomes in oropharyngeal cancer in India. ESTRO 2021
  • Simultaneous integrated boost IMRT versus sequential IMRT in head and neck cancers. ESTRO 2021
  • Comparison of therapy outcomes between 2-dimensional radiotherapy and IMRT for early glottic cancer. ESTRO 2021
  • Wide histological spectrum of sinonasal malignancies and survival outcomes – An institutional review. ESTRO 2021

PUBLISHED CHAPTERS & REVIEWS

  • Cancers of Head and Neck. In Gaura K Rath, Bidhu K Mohanti (Eds) Text Book of Radiation Oncology- Principles and Practice. B I Churchill Livingston Pp 131-199.
  • Paediatric Oncology. In Gaura K Rath, Bidhu K Mohanti (Eds) Text Book of Radiation Oncology- Principles and Practice. B I Churchill Livingston Pp 669-720.
  • Radiotherapy in Juvenile Angiofibroma
  • Role Of Radiotherapy In Cranipharyngioma
  • Brachytherapy In Soft Tissue Sarcoma
  • Stereotaxy In Pituitary Adenoma
  • Radiotherapy in Kaposi Sarcoma
  • Radiotherapy in Age Related Macular Degeneration
  • Intravaginal Brachytherapy by Ovoids to Control Vaginal Bleeding In Cervical Cancers. Should The Haemostatic Dose Be Disregarded ?
  • Organ Preservation In Muscle Invasive Bladder Tumor
  • Brachytherapy Alone or in Combination with External Beam Radiation in the Postoperative Management of Stage I & II Endometrial Carcinoma
  • Palliative Care Education And Training During Residency: A Survey Among Residents at A Tertiary Care Hospital
  • Medical Disorders Associated with Endometrial Cancer
  • Primary Spinal Epidural Ewing’s Sarcoma: Report of 5 Cases and Review Of Literature
  • Brachytherapy In Lung Cancer
  • Late Reaction In Normal Tissue Following External Beam Radiotherapy In Carcinoma Cervix: An Overview
  • External Beam Radiotherapy and Thyroid Disorders

Membership

  • Life Member of Cancer Prevention and Education Society, India
  • Life Member of Association of Radiation Oncologist of India (AROI)
  • Association of Northern Chapter of AROI
  • Member European Society of Medical Oncology (ESMO)

Opportunity to Help

DONATE FOR CANCER CARE

As a society, RGCIRC is looking forward to get support from generous people

Read More
DONATE BLOOD

It is a fact that there are absolutely no substitutes to replace human bloo...

Read More
DONATE TIME (VOLUNTEER)

Volunteers play an important role in today’s hospitals. They help the hos...

Read More

Rajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.

D - 18, Sector - 5, Rohini, Delhi - 110085 | +91-11-47022222
OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday)
Emergency Services: 24x7 All weekdays

Mahendra Kumar Jain Marg, Niti Bagh, New Delhi - 110049 | Tel: +91-11-45822222 / 2200
OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday)
Emergency Services: 24x7 All Weekdays

Subscribe Today For Our Healthy Tips Newsletter
Loading